Peapod Lane Capital LLC Aclaris Therapeutics, Inc. Transaction History
Peapod Lane Capital LLC
- $101 Billion
- Q4 2024
A detailed history of Peapod Lane Capital LLC transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Peapod Lane Capital LLC holds 404,452 shares of ACRS stock, worth $954,506. This represents 0.99% of its overall portfolio holdings.
Number of Shares
404,452Holding current value
$954,506% of portfolio
0.99%Shares
1 transactions
Others Institutions Holding ACRS
# of Institutions
83Shares Held
49.3MCall Options Held
30.6KPut Options Held
1K-
Bml Capital Management, LLC Zionsville, IN14.3MShares$33.6 Million9.64% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.69MShares$11.1 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.37MShares$7.96 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.01MShares$7.09 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.75MShares$6.5 Million0.11% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $157M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...